Stock search

Ticker or company name

Compare stocks

Market: US

  • RMDResMed
  • CNCCentene Corporation
  • DXCMDexcom

Add stock

Ticker or company

Summary

RMD
ResMed
$238,19Down −0,56%
Year: Down −5%
83/100Ratio would consider buying
Open stock page
CNC
Centene Corporation
$74,77Up +4,91%
Year: Up +94%
72/100Ratio would consider buying
Open stock page
DXCM
Dexcom
$81,61Down −2,06%
Year: Up +40%
89/100Best scoreRatio would consider buying
Open stock page

Verdict

DXCM has the best score (89). CNC grows revenue the fastest. CNC is the cheapest by forward P/E. CNC has the lowest debt load. RMD has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckRMD6 ✓ 3 — 0 ✕CNC5 ✓ 3 — 1 ✕DXCM8 ✓ 0 — 1 ✕
P/E vs its history21,324,231,4
P/E vs industry21,324,231,4
Forward P/E18,413,526,8
Revenue growth, YoY+9,0%+9,7%+13,0%
EPS growth, YoY+12,4%—+41,1%
Net margin27,8%0,7%19,4%
Net debt / EBITDA−0,4−3,6−0,6
Free cash flow$1,61 bn$3,94 bn$1,10 bn
Share count over a year−2,4%+0,6%−5,9%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterRMDTTMCNCTTMDXCMTTMIndustry medianTTM
P/E TTM ↓Best: 21,324,2Worst: 31,425,1
Forward P/E ↓18,4Best: 13,5Worst: 26,816,2
PEG ↓Worst: 1,8n/aBest: 1,42,2
P/S TTM ↓5,9Best: 0,2Worst: 6,12,2
EV/EBITDA ↓16,7Best: 13,5Worst: 21,017,3
P/FCF ↓21,4Best: 4,0Worst: 28,319,5

Price, %

  • RMDn/a
  • CNCn/a
  • DXCMn/a

Returns

Best WorstNo mark — in between

PeriodRMDCNCDXCM
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

RMDCNCDXCM
Share of “buy”52%Worst: 48%Best: 89%
Beat the forecastBest: 4 of 4Best: 4 of 4Worst: 3 of 4
Average “surprise”+3,1%Best: +63,6%Worst: +0,9%
Insiders over 12 monthssales $20,2 msales $14,6 msales $12,2 m

Details are on each stock page.